These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
552 related articles for article (PubMed ID: 29306476)
21. The CHA Wang CJ; Hsieh YP; Kor CT; Chiu PF Int Urol Nephrol; 2020 Aug; 52(8):1523-1531. PubMed ID: 32488758 [TBL] [Abstract][Full Text] [Related]
22. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study. Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231 [TBL] [Abstract][Full Text] [Related]
23. Chronic Kidney Disease as a Possible Predictor of Left Atrial Thrombogenic Milieu Among Patients with Nonvalvular Atrial Fibrillation. Kizawa S; Ito T; Akamatsu K; Ichihara N; Nogi S; Miyamura M; Kanzaki Y; Sohmiya K; Hoshiga M Am J Cardiol; 2018 Dec; 122(12):2062-2067. PubMed ID: 30293657 [TBL] [Abstract][Full Text] [Related]
24. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation. Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744 [TBL] [Abstract][Full Text] [Related]
25. Stroke Risk as a Function of Atrial Fibrillation Duration and CHA Kaplan RM; Koehler J; Ziegler PD; Sarkar S; Zweibel S; Passman RS Circulation; 2019 Nov; 140(20):1639-1646. PubMed ID: 31564126 [TBL] [Abstract][Full Text] [Related]
26. The CHADS Barkas F; Elisaf M; Korantzopoulos P; Tsiara S; Liberopoulos E Int J Cardiol; 2017 Aug; 241():194-199. PubMed ID: 28442233 [TBL] [Abstract][Full Text] [Related]
27. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation. Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809 [TBL] [Abstract][Full Text] [Related]
28. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry. Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706 [TBL] [Abstract][Full Text] [Related]
29. Changes in renal function after catheter ablation of atrial fibrillation are associated with CHADS2 and CHA2DS2-VASc scores and arrhythmia recurrences. Kornej J; Hindricks G; Banerjee A; Arya A; Sommer P; Rolf S; Husser D; Lip GY; Bollmann A Heart; 2015 Jan; 101(2):126-31. PubMed ID: 25281600 [TBL] [Abstract][Full Text] [Related]
31. Comparisons of changes in the adapted diabetes complications severity index and CHA2DS2-VASc score for atrial fibrillation risk stratification in patients with type 2 diabetes mellitus: A nationwide cohort study. Hu WS; Hsieh MH; Lin CL Int J Cardiol; 2018 Oct; 269():122-125. PubMed ID: 30037627 [TBL] [Abstract][Full Text] [Related]
32. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation. Letsas KP; Efremidis M; Giannopoulos G; Deftereos S; Lioni L; Korantzopoulos P; Vlachos K; Xydonas S; Kossyvakis C; Sideris A Europace; 2014 Feb; 16(2):202-7. PubMed ID: 23813452 [TBL] [Abstract][Full Text] [Related]
33. Dynamic Changes of CHA2DS2-VASc Score and the Risk of Ischaemic Stroke in Asian Patients with Atrial Fibrillation: A Nationwide Cohort Study. Yoon M; Yang PS; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Pak HN; Lee MH; Lip GYH; Joung B Thromb Haemost; 2018 Jul; 118(7):1296-1304. PubMed ID: 29723875 [TBL] [Abstract][Full Text] [Related]
34. Usefulness of CHADS2 and CHA2DS2-VASc Scores in the Prediction of New-Onset Atrial Fibrillation: A Population-Based Study. Saliba W; Gronich N; Barnett-Griness O; Rennert G Am J Med; 2016 Aug; 129(8):843-9. PubMed ID: 27012854 [TBL] [Abstract][Full Text] [Related]
35. Role of CHA Hu WS; Lin CL BMJ Open; 2018 Mar; 8(3):e020065. PubMed ID: 29567851 [TBL] [Abstract][Full Text] [Related]
36. Prevalence and predictors of inappropriate anticoagulation in patients with a CHA Saberian S; Badin A; Siebert V; Roy A; Banga S; Ghadiam HR; Wigant RR; Aggarwal A; Baman TS Int J Cardiol; 2017 Dec; 248():179-181. PubMed ID: 28807511 [TBL] [Abstract][Full Text] [Related]
37. Sequential changes in renal function and the risk of stroke and death in patients with atrial fibrillation. Guo Y; Wang H; Zhao X; Zhang Y; Zhang D; Ma J; Wang Y; Lip GY Int J Cardiol; 2013 Oct; 168(5):4678-84. PubMed ID: 23972369 [TBL] [Abstract][Full Text] [Related]
38. Predictive value of fine fibrillatory wave for declining eGFR in patients with persistent atrial fibrillation: Long-term follow-up study. Lan Z; Cheng S; Han Y; Jiang L; Li CW; Guo J Int J Cardiol; 2024 Dec; 417():132521. PubMed ID: 39244098 [TBL] [Abstract][Full Text] [Related]
39. Does the CHA Rovaris G; Solimene F; D'Onofrio A; Zanotto G; Ricci RP; Mazzella T; Iacopino S; Della Bella P; Maglia G; Senatore G; Quartieri F; Biffi M; Curnis A; Calvi V; Rapacciuolo A; Santamaria M; Capucci A; Giammaria M; Campana A; Caravati F; Giacopelli D; Gargaro A; Pisanò EC Heart Rhythm; 2018 Jul; 15(7):971-979. PubMed ID: 29477974 [TBL] [Abstract][Full Text] [Related]